InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0001415889-25-017665 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-18 2025-06-16 WGS Feeley Kevin CFO M - OptEx $0.00 -7,197 12.5K -37% $0
D 2025-06-18 2025-06-16 WGS Feeley Kevin CFO S - Sale+OE $64.77 -3,729 8,769 -30% -$241.5K
D 2025-06-18 2025-06-16 WGS Feeley Kevin CFO M - OptEx $0.00 -7,197 50.4K -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-06-16 M D 7,197 $0.00 12,498 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2025-06-16 S D 3,729 $64.77 8,769 D — —
3 Derivative Restricted Stock Unit 2025-06-16 M D 7,197 $0.00 50,378 D — · — to — 7,197 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.